Etiometry Raises $9M In Series A-3 Funding To Fuel Business And Leadership Team Expansion, R&Amp;D Acceleration, And Clinical Initiatives

Jun 03, 2021•about 4 years ago

Amount Raised

$9 Million

Round Type

series a

Boston

Description

Etiometry, a leader in clinical decision-support software for the intensive care environment, today announced a fully subscribed $9 million Series A-3 extension raise to fund commercial expansion, accelerate vital research and development, support leadership team expansion, and drive clinical initiatives. This latest round of funding was led by SKK 9i Ventures, with participation from Shamrock Holdings and other healthcare investors. The additional capital comes after significant growth and expansion in 2020 and will be used to help extend use of the company’s software to other hospital care settings.

Company Information

Company

Etiometry

Location

Boston, Massachusetts, United States

About

Founded in 2010, Etiometry is the leader in clinical decision-support software designed to help clinicians in the intensive care setting make data-based decisions regarding their patients’ care and treatment. The company’s technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patients’ conditions to avoid complications and speed recovery. With roots in the pediatric ICU space, Etiometry’s software is used in more than 20 of the top children’s hospitals in the United States and several adult ICUs at a number of leading U.S. medical centers. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering the cost of care through the more effective use of all available data. To learn more, visit www.etiometry.com.